Code | Display | Definition | status | nonvaccine | lastupdated |
54 |
adenovirus, type 4 |
adenovirus vaccine, type 4, live, oral |
Inactive |
False |
2010-05-28 |
55 |
adenovirus, type 7 |
adenovirus vaccine, type 7, live, oral |
Inactive |
False |
2010-05-28 |
82 |
adenovirus, unspecified formulation |
adenovirus vaccine, unspecified formulation |
Inactive |
False |
2010-09-30 |
24 |
Anthrax, pre-exposure prophylaxis, post-exposure prophylaxis |
Anthrax vaccine, adsorbed, pre-exposure and post-exposure prophylaxis |
Active |
False |
2024-01-25 |
19 |
BCG |
Bacillus Calmette-Guerin vaccine |
Active |
False |
2010-05-28 |
27 |
botulinum antitoxin |
botulinum antitoxin |
Active |
True |
2020-09-04 |
26 |
cholera, unspecified formulation |
cholera vaccine, unspecified formulation |
Inactive |
False |
2016-06-17 |
29 |
CMVIG |
cytomegalovirus immune globulin, intravenous |
Active |
True |
2020-09-04 |
56 |
dengue fever tetravalent |
dengue fever vaccine, tetravalent |
Active |
False |
2023-02-16 |
12 |
diphtheria antitoxin |
diphtheria antitoxin |
Active |
True |
2020-09-04 |
28 |
DT (pediatric) |
diphtheria and tetanus toxoids, adsorbed for pediatric use |
Active |
False |
2010-05-28 |
20 |
DTaP |
diphtheria, tetanus toxoids and acellular pertussis vaccine |
Active |
False |
2010-05-28 |
106 |
DTaP, 5 pertussis antigens |
diphtheria, tetanus toxoids and acellular pertussis vaccine, 5 pertussis antigens |
Active |
False |
2010-05-28 |
107 |
DTaP, unspecified formulation |
diphtheria, tetanus toxoids and acellular pertussis vaccine, unspecified formulation |
Inactive |
False |
2010-09-30 |
110 |
DTaP-Hep B-IPV |
DTaP-hepatitis B and poliovirus vaccine |
Active |
False |
2010-05-28 |
50 |
DTaP-Hib |
DTaP-Haemophilus influenzae type b conjugate vaccine |
Inactive |
False |
2017-03-20 |
120 |
DTaP-Hib-IPV |
diphtheria, tetanus toxoids and acellular pertussis vaccine, Haemophilus influenzae type b conjugate, and poliovirus vaccine, inactivated (DTaP-Hib-IPV) |
Active |
False |
2010-05-28 |
130 |
DTaP-IPV |
Diphtheria, tetanus toxoids and acellular pertussis vaccine, and poliovirus vaccine, inactivated |
Active |
False |
2010-05-28 |
1 |
DTP |
diphtheria, tetanus toxoids and pertussis vaccine |
Inactive |
False |
2010-05-28 |
22 |
DTP-Hib |
DTP-Haemophilus influenzae type b conjugate vaccine |
Inactive |
False |
2017-03-23 |
102 |
DTP-Hib-Hep B |
DTP- Haemophilus influenzae type b conjugate and hepatitis b vaccine |
Non-US |
False |
2016-05-20 |
57 |
hantavirus |
hantavirus vaccine |
Never Active |
False |
2020-09-09 |
52 |
Hep A, adult |
hepatitis A vaccine, adult dosage |
Active |
False |
2010-05-28 |
83 |
Hep A, ped/adol, 2 dose |
hepatitis A vaccine, pediatric/adolescent dosage, 2 dose schedule |
Active |
False |
2010-05-28 |
84 |
Hep A, ped/adol, 3 dose |
hepatitis A vaccine, pediatric/adolescent dosage, 3 dose schedule |
Inactive |
False |
2010-05-28 |
31 |
Hep A, pediatric, unspecified formulation |
hepatitis A vaccine, pediatric dosage, unspecified formulation |
Inactive |
False |
2010-09-30 |
85 |
Hep A, unspecified formulation |
hepatitis A vaccine, unspecified formulation |
Inactive |
False |
2010-09-30 |
104 |
Hep A-Hep B |
hepatitis A and hepatitis B vaccine |
Active |
False |
2010-05-28 |
30 |
HBIG |
hepatitis B immune globulin |
Active |
True |
2020-09-04 |
8 |
Hep B, adolescent or pediatric |
hepatitis B vaccine, pediatric or pediatric/adolescent dosage |
Active |
False |
2018-05-10 |
42 |
Hep B, adolescent/high risk infant |
hepatitis B vaccine, adolescent/high risk infant dosage |
Inactive |
False |
2010-05-28 |
43 |
Hep B, adult |
hepatitis B vaccine, adult dosage |
Active |
False |
2018-05-10 |
44 |
Hep B, dialysis |
hepatitis B vaccine, dialysis patient dosage |
Active |
False |
2019-05-08 |
45 |
Hep B, unspecified formulation |
hepatitis B vaccine, unspecified formulation |
Inactive |
False |
2010-09-30 |
58 |
Hep C |
hepatitis C vaccine |
Never Active |
False |
2020-09-09 |
59 |
Hep E |
hepatitis E vaccine |
Never Active |
False |
2020-09-09 |
60 |
herpes simplex 2 |
herpes simplex virus, type 2 vaccine |
Never Active |
False |
2020-09-09 |
46 |
Hib (PRP-D) |
Haemophilus influenzae type b vaccine, PRP-D conjugate |
Inactive |
False |
2010-05-28 |
47 |
Hib (HbOC) |
Haemophilus influenzae type b vaccine, HbOC conjugate |
Inactive |
False |
2010-05-28 |
48 |
Hib (PRP-T) |
Haemophilus influenzae type b vaccine, PRP-T conjugate |
Active |
False |
2010-05-28 |
49 |
Hib (PRP-OMP) |
Haemophilus influenzae type b vaccine, PRP-OMP conjugate |
Active |
False |
2010-05-28 |
17 |
Hib, unspecified formulation |
Haemophilus influenzae type b vaccine, conjugate unspecified formulation |
Inactive |
False |
2010-09-30 |
51 |
Hib-Hep B |
Haemophilus influenzae type b conjugate and Hepatitis B vaccine |
Inactive |
False |
2016-03-11 |
61 |
HIV |
human immunodeficiency virus vaccine |
Never Active |
False |
2020-09-09 |
118 |
HPV, bivalent |
human papilloma virus vaccine, bivalent |
Inactive |
False |
2010-05-28 |
62 |
HPV, quadrivalent |
human papilloma virus vaccine, quadrivalent |
Active |
False |
2020-06-02 |
86 |
IG |
immune globulin, intramuscular |
Active |
True |
2020-09-04 |
87 |
IGIV |
immune globulin, intravenous |
Active |
True |
2020-09-04 |
14 |
IG, unspecified formulation |
immune globulin, unspecified formulation |
Inactive |
True |
2023-03-09 |
111 |
influenza, live, intranasal |
influenza virus vaccine, live, attenuated, for intranasal use |
Inactive |
False |
2014-09-22 |
15 |
influenza, split (incl. purified surface antigen) |
influenza virus vaccine, split virus (incl. purified surface antigen)-retired CODE |
Inactive |
False |
2010-09-30 |
16 |
influenza, whole |
influenza virus vaccine, whole virus |
Inactive |
False |
2010-05-28 |
88 |
influenza, unspecified formulation |
influenza virus vaccine, unspecified formulation |
Inactive |
False |
2010-09-30 |
123 |
influenza, H5N1-1203 |
influenza virus vaccine, H5N1, A/Vietnam/1203/2004 (national stockpile) |
Inactive |
False |
2010-05-28 |
10 |
IPV |
poliovirus vaccine, inactivated |
Active |
False |
2010-05-28 |
2 |
OPV |
trivalent poliovirus vaccine, live, oral |
Inactive |
False |
2017-02-10 |
89 |
polio, unspecified formulation |
poliovirus vaccine, unspecified formulation |
Inactive |
False |
2010-09-30 |
39 |
Japanese encephalitis SC |
Japanese Encephalitis Vaccine SC |
Inactive |
False |
2015-09-24 |
63 |
Junin virus |
Junin virus vaccine |
Never Active |
False |
2020-09-09 |
64 |
leishmaniasis |
leishmaniasis vaccine |
Never Active |
False |
2020-09-09 |
65 |
leprosy |
leprosy vaccine |
Never Active |
False |
2020-09-09 |
66 |
Lyme disease |
Lyme disease vaccine |
Inactive |
False |
2010-05-28 |
3 |
MMR |
measles, mumps and rubella virus vaccine |
Active |
False |
2010-05-28 |
4 |
M/R |
measles and rubella virus vaccine |
Inactive |
False |
2010-05-28 |
94 |
MMRV |
measles, mumps, rubella, and varicella virus vaccine |
Active |
False |
2010-05-28 |
67 |
malaria |
malaria vaccine |
Never Active |
False |
2020-09-09 |
5 |
measles |
measles virus vaccine |
Inactive |
False |
2010-08-31 |
68 |
melanoma |
melanoma vaccine |
Never Active |
False |
2020-09-09 |
32 |
meningococcal MPSV4 |
meningococcal polysaccharide vaccine (MPSV4) |
Inactive |
False |
2017-10-27 |
103 |
meningococcal C conjugate |
meningococcal C conjugate vaccine |
Inactive |
False |
2010-05-28 |
114 |
meningococcal MCV4P |
meningococcal polysaccharide (groups A, C, Y and W-135) diphtheria toxoid conjugate vaccine (MCV4P) |
Active |
False |
2010-05-28 |
108 |
meningococcal ACWY, unspecified formulation |
meningococcal ACWY vaccine, unspecified formulation |
Inactive |
False |
2015-12-01 |
7 |
mumps |
mumps virus vaccine |
Inactive |
False |
2015-06-18 |
69 |
parainfluenza-3 |
parainfluenza-3 virus vaccine |
Inactive |
False |
2010-05-28 |
11 |
pertussis |
pertussis vaccine |
Inactive |
False |
2010-05-28 |
23 |
plague |
plague vaccine |
Inactive |
False |
2018-05-17 |
33 |
pneumococcal polysaccharide PPV23 |
pneumococcal polysaccharide vaccine, 23 valent |
Active |
False |
2010-05-28 |
100 |
pneumococcal conjugate PCV 7 |
pneumococcal conjugate vaccine, 7 valent |
Inactive |
False |
2014-06-26 |
109 |
pneumococcal, unspecified formulation |
pneumococcal vaccine, unspecified formulation |
Inactive |
False |
2010-09-30 |
70 |
Q fever |
Q fever vaccine |
Never Active |
False |
2020-09-09 |
18 |
rabies, intramuscular injection |
rabies vaccine, for intramuscular injection RETIRED CODE |
Inactive |
False |
2016-10-18 |
40 |
rabies, intradermal injection |
rabies vaccine, for intradermal injection |
Inactive |
False |
2015-06-18 |
90 |
rabies, unspecified formulation |
rabies vaccine, unspecified formulation |
Inactive |
False |
2010-09-30 |
72 |
rheumatic fever |
rheumatic fever vaccine |
Never Active |
False |
2020-09-09 |
73 |
Rift Valley fever |
Rift Valley fever vaccine |
Never Active |
False |
2020-09-09 |
34 |
RIG |
rabies immune globulin |
Active |
True |
2020-09-04 |
119 |
rotavirus, monovalent |
rotavirus, live, monovalent vaccine |
Active |
False |
2010-05-28 |
122 |
rotavirus, unspecified formulation |
rotavirus vaccine, unspecified formulation |
Inactive |
False |
2010-09-30 |
116 |
rotavirus, pentavalent |
rotavirus, live, pentavalent vaccine |
Active |
False |
2010-05-28 |
74 |
rotavirus, tetravalent |
rotavirus, live, tetravalent vaccine |
Inactive |
False |
2010-05-28 |
71 |
RSV-IGIV |
respiratory syncytial virus immune globulin, intravenous |
Inactive |
True |
2023-07-19 |
93 |
RSV-MAb |
respiratory syncytial virus monoclonal antibody (palivizumab), intramuscular |
Active |
True |
2020-09-04 |
6 |
rubella |
rubella virus vaccine |
Inactive |
False |
2015-06-18 |
38 |
rubella/mumps |
rubella and mumps virus vaccine |
Inactive |
False |
2010-05-28 |
76 |
Staphylococcus bacterio lysate |
Staphylococcus bacteriophage lysate |
Inactive |
True |
2023-03-09 |
113 |
Td (adult), 5 Lf tetanus toxoid, preservative free, adsorbed |
tetanus and diphtheria toxoids, adsorbed, preservative free, for adult use (5 Lf of tetanus toxoid and 2 Lf of diphtheria toxoid) |
Active |
False |
2024-01-25 |
9 |
Td (adult), 2 Lf tetanus toxoid, preservative free, adsorbed |
tetanus and diphtheria toxoids, adsorbed, preservative free, for adult use (2 Lf of tetanus toxoid and 2 Lf of diphtheria toxoid) |
Active |
False |
2017-10-27 |
115 |
Tdap |
tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine, adsorbed |
Active |
False |
2010-05-28 |
35 |
tetanus toxoid, adsorbed |
tetanus toxoid, adsorbed |
Inactive |
False |
2015-08-14 |
112 |
tetanus toxoid, unspecified formulation |
tetanus toxoid, unspecified formulation |
Inactive |
False |
2010-09-30 |
77 |
Tick-borne encephalitis vaccine (non-US) |
Tick-borne encephalitis vaccine (non-US) |
Non-US |
False |
2022-03-04 |
13 |
TIG |
tetanus immune globulin |
Active |
True |
2020-09-04 |
95 |
TST-OT tine test |
tuberculin skin test; old tuberculin, multipuncture device |
Inactive |
True |
2023-03-09 |
96 |
TST-PPD intradermal |
tuberculin skin test; purified protein derivative solution, intradermal |
Inactive |
True |
2023-03-09 |
97 |
TST-PPD tine test |
tuberculin skin test; purified protein derivative, multipuncture device |
Inactive |
True |
2023-03-09 |
98 |
TST, unspecified formulation |
tuberculin skin test; unspecified formulation |
Inactive |
True |
2023-03-09 |
78 |
tularemia vaccine |
tularemia vaccine |
Inactive |
False |
2010-05-28 |
91 |
typhoid, unspecified formulation |
typhoid vaccine, unspecified formulation |
Inactive |
False |
2010-09-30 |
25 |
typhoid, oral |
typhoid vaccine, live, oral |
Active |
False |
2010-05-28 |
41 |
typhoid, parenteral |
typhoid vaccine, parenteral, other than acetone-killed, dried |
Inactive |
False |
2015-08-13 |
53 |
typhoid, parenteral, AKD (U.S. military) |
typhoid vaccine, parenteral, acetone-killed, dried (U.S. military) |
Inactive |
False |
2015-06-18 |
101 |
typhoid, ViCPs |
typhoid Vi capsular polysaccharide vaccine |
Active |
False |
2010-05-28 |
75 |
vaccinia (smallpox) |
vaccinia (smallpox) vaccine |
Active |
False |
2010-05-28 |
105 |
vaccinia (smallpox) diluted |
vaccinia (smallpox) vaccine, diluted |
Inactive |
False |
2010-05-28 |
79 |
vaccinia immune globulin |
vaccinia immune globulin |
Active |
True |
2020-09-04 |
21 |
varicella |
varicella virus vaccine |
Active |
False |
2010-05-28 |
81 |
VEE, inactivated |
Venezuelan equine encephalitis, inactivated |
Inactive |
False |
2010-05-28 |
80 |
VEE, live |
Venezuelan equine encephalitis, live, attenuated |
Inactive |
False |
2010-05-28 |
92 |
VEE, unspecified formulation |
Venezuelan equine encephalitis vaccine, unspecified formulation |
Inactive |
False |
2010-09-30 |
36 |
VZIG |
varicella zoster immune globulin |
Active |
True |
2020-09-04 |
117 |
VZIG (IND) |
varicella zoster immune globulin (Investigational New Drug) |
Never Active |
True |
2020-09-09 |
37 |
yellow fever live |
yellow fever vaccine live |
Active |
False |
2024-03-07 |
121 |
zoster live |
zoster vaccine, live |
Active |
False |
2010-05-28 |
998 |
no vaccine administered |
no vaccine administered |
Inactive |
True |
2023-03-09 |
999 |
unknown |
unknown vaccine or immune globulin |
Inactive |
True |
2020-10-27 |
99 |
RESERVED - do not use |
RESERVED - do not use |
Inactive |
True |
2020-09-09 |
133 |
Pneumococcal conjugate PCV 13 |
pneumococcal conjugate vaccine, 13 valent |
Active |
False |
2010-05-28 |
134 |
Japanese Encephalitis IM |
Japanese Encephalitis vaccine for intramuscular administration |
Active |
False |
2010-05-28 |
137 |
HPV, unspecified formulation |
HPV, unspecified formulation |
Inactive |
False |
2010-09-30 |
136 |
Meningococcal MCV4O |
meningococcal oligosaccharide (groups A, C, Y and W-135) diphtheria toxoid conjugate vaccine (MCV4O) |
Active |
False |
2010-05-28 |
135 |
Influenza, high dose seasonal |
influenza, high dose seasonal, preservative-free |
Active |
False |
2010-05-28 |
131 |
typhus, historical |
Historical record of a typhus vaccination |
Inactive |
False |
2010-05-28 |
132 |
DTaP-IPV-HIB-HEP B, historical |
Historical diphtheria and tetanus toxoids and acellular pertussis, poliovirus, Haemophilus b conjugate and hepatitis B (recombinant) vaccine. |
Inactive |
False |
2018-05-10 |
128 |
Novel Influenza-H1N1-09, all formulations |
Novel influenza-H1N1-09, all formulations |
Inactive |
False |
2010-08-28 |
125 |
Novel Influenza-H1N1-09, nasal |
Novel Influenza-H1N1-09, live virus for nasal administration |
Inactive |
False |
2010-08-28 |
126 |
Novel influenza-H1N1-09, preservative-free |
Novel influenza-H1N1-09, preservative-free, injectable |
Inactive |
False |
2010-08-28 |
127 |
Novel influenza-H1N1-09 |
Novel influenza-H1N1-09, injectable |
Inactive |
False |
2010-08-28 |
138 |
Td (adult) |
tetanus and diphtheria toxoids, not adsorbed, for adult use |
Inactive |
False |
2010-09-30 |
139 |
Td(adult) unspecified formulation |
Td(adult) unspecified formulation |
Inactive |
False |
2019-08-27 |
140 |
Influenza, seasonal, injectable, preservative free |
Influenza, seasonal, injectable, preservative free |
Inactive |
False |
2022-12-15 |
129 |
Japanese Encephalitis, unspecified formulation |
Japanese Encephalitis vaccine, unspecified formulation |
Inactive |
False |
2010-09-30 |
141 |
Influenza, seasonal, injectable |
Influenza, seasonal, injectable |
Active |
False |
2013-07-17 |
142 |
tetanus toxoid, not adsorbed |
tetanus toxoid, not adsorbed |
Inactive |
False |
2015-08-14 |
143 |
Adenovirus types 4 and 7 |
Adenovirus, type 4 and type 7, live, oral |
Active |
False |
2011-03-20 |
144 |
influenza, seasonal, intradermal, preservative free |
seasonal influenza, intradermal, preservative free |
Inactive |
False |
2022-12-15 |
145 |
RSV-MAb (new) |
respiratory syncytial virus monoclonal antibody (motavizumab), intramuscular |
Never Active |
True |
2020-09-09 |
146 |
DTaP,IPV,Hib,HepB |
Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus, Haemophilus b Conjugate (Meningococcal Protein Conjugate), and Hepatitis B (Recombinant) Vaccine. |
Active |
False |
2022-08-10 |
147 |
meningococcal MCV4, unspecified formulation |
Meningococcal, MCV4, unspecified conjugate formulation(groups A, C, Y and W-135) |
Inactive |
False |
2012-02-08 |
148 |
Meningococcal C/Y-HIB PRP |
Meningococcal Groups C and Y and Haemophilus b Tetanus Toxoid Conjugate Vaccine |
Inactive |
False |
2018-05-11 |
149 |
influenza, live, intranasal, quadrivalent |
influenza, live, intranasal, quadrivalent |
Active |
False |
2013-07-17 |
150 |
influenza, injectable, quadrivalent, preservative free |
Influenza, injectable, quadrivalent, preservative free |
Active |
False |
2013-07-17 |
151 |
influenza nasal, unspecified formulation |
influenza nasal, unspecified formulation |
Inactive |
False |
2013-01-28 |
152 |
Pneumococcal Conjugate, unspecified formulation |
Pneumococcal Conjugate, unspecified formulation |
Inactive |
False |
2013-01-28 |
153 |
Influenza, injectable, MDCK, preservative free |
Influenza, injectable, Madin Darby Canine Kidney, preservative free |
Inactive |
False |
2016-06-24 |
154 |
Hep A, IG |
Hepatitis A immune globulin |
Never Active |
True |
2020-09-09 |
155 |
influenza, recombinant, injectable, preservative free |
Seasonal, trivalent, recombinant, injectable influenza vaccine, preservative free |
Active |
False |
2013-07-17 |
156 |
Rho(D)-IG |
Rho(D) Immune globulin- IV or IM |
Active |
True |
2020-09-04 |
157 |
Rho(D) -IG IM |
Rho(D) Immune globulin - IM |
Active |
True |
2020-09-04 |
158 |
influenza, injectable, quadrivalent |
influenza, injectable, quadrivalent, contains preservative |
Active |
False |
2013-08-20 |
159 |
Rho(D) - Unspecified formulation |
Rho(D) Unspecified formulation |
Inactive |
True |
2023-03-09 |
160 |
Influenza A monovalent (H5N1), ADJUVANTED-2013 |
Influenza A monovalent (H5N1), adjuvanted, National stockpile 2013 |
Active |
False |
2014-05-27 |
801 |
AS03 Adjuvant |
AS03 Adjuvant |
Active |
True |
2020-10-27 |
161 |
Influenza, injectable,quadrivalent, preservative free, pediatric |
Influenza, injectable,quadrivalent, preservative free, pediatric |
Active |
False |
2014-07-23 |
162 |
meningococcal B, recombinant |
meningococcal B vaccine, fully recombinant |
Active |
False |
2014-11-03 |
163 |
meningococcal B, OMV |
meningococcal B vaccine, recombinant, OMV, adjuvanted |
Active |
False |
2015-02-02 |
164 |
meningococcal B, unspecified |
meningococcal B, unspecified formulation |
Inactive |
False |
2014-11-03 |
165 |
HPV9 |
Human Papillomavirus 9-valent vaccine |
Active |
False |
2014-12-11 |
166 |
influenza, intradermal, quadrivalent, preservative free |
influenza, intradermal, quadrivalent, preservative free, injectable |
Inactive |
False |
2022-12-15 |
167 |
meningococcal, unknown serogroups |
meningococcal vaccine of unknown formulation and unknown serogroups |
Inactive |
False |
2015-12-01 |
168 |
influenza, trivalent, adjuvanted |
Seasonal trivalent influenza vaccine, adjuvanted, preservative free |
Active |
False |
2015-12-10 |
169 |
Hep A, live attenuated |
Hep A, live attenuated-IM |
Non-US |
False |
2016-05-10 |
170 |
DTAP/IPV/HIB - non-US |
non-US diphtheria, tetanus toxoids and acellular pertussis vaccine, Haemophilus influenzae type b conjugate, and poliovirus vaccine, inactivated (DTaP-Hib-IPV) |
Non-US |
False |
2016-05-20 |
171 |
Influenza, injectable, MDCK, preservative free, quadrivalent |
Influenza, injectable, Madin Darby Canine Kidney, preservative free, quadrivalent |
Active |
False |
2024-01-25 |
172 |
cholera, WC-rBS |
cholera, WC-rBS |
Non-US |
False |
2016-06-17 |
173 |
cholera, BivWC |
cholera, BivWC |
Non-US |
False |
2016-06-17 |
174 |
cholera, live attenuated |
cholera, live attenuated |
Active |
False |
2016-06-17 |
175 |
Rabies - IM Diploid cell culture |
Human Rabies vaccine from human diploid cell culture |
Active |
False |
2016-10-18 |
176 |
Rabies - IM fibroblast culture |
Human rabies vaccine from Chicken fibroblast culture |
Active |
False |
2016-10-18 |
177 |
PCV10 |
pneumococcal conjugate vaccine, 10 valent |
Non-US |
False |
2016-12-19 |
178 |
OPV bivalent |
Non-US bivalent oral polio vaccine (types 1 and 3) |
Non-US |
False |
2017-01-17 |
179 |
OPV ,monovalent, unspecified |
Non-US monovalent oral polio vaccine, unspecified formulation |
Non-US |
False |
2017-01-17 |
180 |
tetanus immune globulin |
tetanus immune globulin |
Inactive |
True |
2020-09-09 |
181 |
anthrax immune globulin |
anthrax immune globulin |
Active |
True |
2020-09-04 |
182 |
OPV, Unspecified |
Oral Polio Vaccine, Unspecified formulation |
Inactive |
False |
2017-01-17 |
183 |
Yellow fever vaccine live - alt |
Yellow fever vaccine live - alternative formulation for vaccine shortage |
Active |
False |
2024-03-07 |
184 |
Yellow fever, unspecified |
Yellow fever vaccine, unspecified formulation |
Inactive |
False |
2024-03-07 |
185 |
influenza, recombinant, quadrivalent,injectable, preservative free |
Seasonal, quadrivalent, recombinant, injectable influenza vaccine, preservative free |
Active |
False |
2017-04-21 |
186 |
Influenza, injectable, MDCK, quadrivalent, preservative |
Influenza, injectable, Madin Darby Canine Kidney, quadrivalent with preservative |
Active |
False |
2024-01-25 |
187 |
zoster recombinant |
zoster vaccine recombinant |
Active |
False |
2017-10-27 |
188 |
zoster, unspecified formulation |
zoster vaccine, unspecified formulation |
Inactive |
False |
2017-10-27 |
189 |
HepB-CpG |
Hepatitis B vaccine (recombinant), CpG adjuvanted |
Active |
False |
2018-05-10 |
190 |
Typhoid conjugate vaccine (TCV) |
Typhoid conjugate vaccine (non-US) |
Non-US |
False |
2023-01-17 |
191 |
meningococcal A polysaccharide (non-US) |
meningococcal A polysaccharide vaccine (non-US) |
Non-US |
False |
2018-05-10 |
192 |
meningococcal AC polysaccharide (non-US) |
meningococcal AC polysaccharide vaccine (non-US) |
Non-US |
False |
2018-05-10 |
193 |
Hep A-Hep B, pediatric/adolescent |
hepatitis A and hepatitis B vaccine, pediatric/adolescent (non-US) |
Non-US |
False |
2018-08-21 |
194 |
Influenza, Southern Hemisphere |
influenza, Southern Hemisphere, unspecified formulation |
Inactive |
False |
2020-07-16 |
195 |
DT, IPV adsorbed |
Diphtheria, Tetanus, Poliomyelitis adsorbed |
Non-US |
False |
2023-01-17 |
196 |
Td, adsorbed, preservative free, adult use, Lf unspecified |
tetanus and diphtheria toxoids, adsorbed, preservative free, for adult use, Lf unspecified |
Active |
False |
2019-08-15 |
197 |
influenza, high-dose, quadrivalent |
influenza, high-dose seasonal, quadrivalent, 0.7mL dose, preservative free |
Active |
False |
2023-01-17 |
200 |
influenza, Southern Hemisphere, pediatric, preservative free |
influenza, seasonal, Southern Hemisphere, quadrivalent, pediatric 0.25mL dose, preservative free |
Active |
False |
2023-01-17 |
201 |
influenza, Southern Hemisphere, preservative free |
influenza, seasonal, Southern Hemisphere, quadrivalent, 0.5mL dose, no preservative |
Active |
False |
2023-01-17 |
202 |
influenza, Southern Hemisphere, quadrivalent, with preservative |
influenza, seasonal, Southern Hemisphere, quadrivalent, 0.5mL dose, with preservative |
Active |
False |
2023-01-17 |
198 |
DTP-hepB-Hib Pentavalent Non-US |
Diphtheria, pertussis, tetanus, hepatitis B, Haemophilus Influenza Type b, (Pentavalent) |
Non-US |
False |
2023-01-17 |
203 |
meningococcal conjugate quadrivalent, MenACWY-TT (MCV4) |
meningococcal polysaccharide (groups A, C, Y, W-135) tetanus toxoid conjugate vaccine 0.5mL dose, preservative free |
Active |
False |
2023-01-26 |
205 |
Influenza vaccine, quadrivalent, adjuvanted |
influenza, seasonal vaccine, quadrivalent, adjuvanted, 0.5mL dose, preservative free |
Active |
False |
2023-01-17 |
206 |
Vaccinia, smallpox Mpox vaccine live, PF, SQ or ID injection |
Vaccinia, smallpox monkeypox vaccine, live attenuated, preservative free, subcutaneous or intradermal injection |
Active |
False |
2023-02-14 |
207 |
COVID-19, mRNA, LNP-S, PF, 100 mcg/0.5mL dose or 50 mcg/0.25mL dose |
SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 100 mcg/0.5mL dose or 50 mcg/0.25mL dose |
Inactive |
False |
2023-10-24 |
208 |
COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose |
SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 30 mcg/0.3mL dose |
Inactive |
False |
2023-11-14 |
213 |
SARS-COV-2 (COVID-19) vaccine, UNSPECIFIED |
SARS-COV-2 (COVID-19) vaccine, UNSPECIFIED |
Inactive |
False |
2021-07-31 |
210 |
COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL |
SARS-COV-2 (COVID-19) vaccine, vector non-replicating, recombinant spike protein-ChAdOx1, preservative free, 0.5 mL |
Non-US |
False |
2024-01-03 |
212 |
COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL |
SARS-COV-2 (COVID-19) vaccine, vector non-replicating, recombinant spike protein-Ad26, preservative free, 0.5 mL |
Inactive |
False |
2023-10-26 |
204 |
Ebola Zaire vaccine, live, recombinant, 1mL dose |
Ebola Zaire vaccine, live, recombinant, 1mL dose |
Active |
False |
2024-01-03 |
214 |
Ebola, unspecified |
Ebola, unspecified |
Inactive |
False |
2021-04-06 |
211 |
COVID-19, subunit, rS-nanoparticle+Matrix-M1 Adjuvant, PF, 0.5 mL |
SARS-COV-2 (COVID-19) vaccine, subunit, recombinant spike protein-nanoparticle+Matrix-M1 Adjuvant, preservative free, 0.5mL dose |
Inactive |
False |
2023-10-24 |
500 |
COVID-19 Non-US Vaccine, Product Unknown |
SARS-COV-2 COVID-19 Non-US Vaccine, Specific Product Unknown |
Non-US |
False |
2021-07-15 |
501 |
COVID-19 IV Non-US Vaccine (QAZCOVID-IN) |
SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (QAZCOVID-IN) |
Non-US |
False |
2021-07-15 |
502 |
COVID-19 IV Non-US Vaccine (COVAXIN) |
SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (COVAXIN) |
Non-US |
False |
2021-11-19 |
503 |
COVID-19 LAV Non-US Vaccine (COVIVAC) |
SARS-COV-2 COVID-19 Live Attenuated Virus Non-US Vaccine Product (COVIVAC) |
Non-US |
False |
2024-01-03 |
504 |
COVID-19 VVnr Non-US Vaccine (Sputnik Light) |
SARS-COV-2 COVID-19 Viral Vector Non-replicating Non-US Vaccine Product (Sputnik Light) |
Non-US |
False |
2021-07-15 |
505 |
COVID-19 VVnr Non-US Vaccine (Sputnik V) |
SARS-COV-2 COVID-19 Viral Vector Non-replicating Non-US Vaccine Product (Sputnik V) |
Non-US |
False |
2021-07-15 |
506 |
COVID-19 VVnr Non-US Vaccine (CanSino Biological Inc./Beijing Institute of Biotechnology |
SARS-COV-2 COVID-19 Viral Vector Non-replicating Non-US Vaccine Product (CONVIDECIA), CanSino Biological Inc./Beijing Institute of Biotechnology |
Non-US |
False |
2022-12-16 |
507 |
COVID-19 PS Non-US Vaccine (Anhui Zhifei Longcom Biopharm + Inst of Micro, Chinese Acad of Sciences) |
SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Anhui Zhifei Longcom Biopharmaceutical + Institute of Microbiology, Chinese Academy of Sciences) |
Non-US |
False |
2021-08-18 |
508 |
COVID-19 PS Non-US Vaccine (Jiangsu Province Centers for Disease Control and Prevention) |
SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Jiangsu Province Centers for Disease Control and Prevention) |
Non-US |
False |
2024-01-03 |
509 |
COVID-19 PS Non-US Vaccine (EpiVacCorona) |
SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (EpiVacCorona) |
Non-US |
False |
2021-07-15 |
510 |
COVID-19 IV Non-US Vaccine (BIBP, Sinopharm) |
SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (BIBP, Sinopharm) |
Non-US |
False |
2022-11-15 |
511 |
COVID-19 IV Non-US Vaccine (CoronaVac, Sinovac) |
SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (CoronaVac, Sinovac) |
Non-US |
False |
2022-11-15 |
215 |
Pneumococcal conjugate PCV15, polysaccharide CRM197 conjugate, adjuvant, PF |
Pneumococcal conjugate vaccine 15-valent (PCV15), polysaccharide CRM197 conjugate, adjuvant, preservative free |
Active |
False |
2021-08-18 |
216 |
Pneumococcal conjugate PCV20, polysaccharide CRM197 conjugate, adjuvant, PF |
Pneumococcal conjugate vaccine 20-valent (PCV20), polysaccharide CRM197 conjugate, adjuvant, preservative free |
Active |
False |
2023-03-09 |
219 |
COVID-19, mRNA, LNP-S, PF, 3 mcg/0.2 mL dose, tris-sucrose |
SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 3 mcg/0.2mL dose, tris-sucrose formulation |
Inactive |
False |
2023-10-26 |
217 |
COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose, tris-sucrose |
SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 30 mcg/0.3mL dose, tris-sucrose formulation |
Inactive |
False |
2023-11-02 |
218 |
COVID-19, mRNA, LNP-S, PF, 10 mcg/0.2 mL dose, tris-sucrose |
SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 10 mcg/0.2mL dose, tris-sucrose formulation |
Inactive |
False |
2023-10-25 |
220 |
HepB recombinant, 3-antigen, Al(OH)3 |
Hepatitis B vaccine (recombinant), 3-antigen, Al(OH)3 adjuvanted |
Active |
False |
2022-02-14 |
221 |
COVID-19, mRNA, LNP-S, PF, 50 mcg/0.5 mL dose |
SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 50 mcg/0.5 mL dose |
Inactive |
False |
2023-10-25 |
222 |
Tick-borne encephalitis, unspecified |
Tick-borne encephalitis vaccine, unspecified |
Inactive |
False |
2022-03-16 |
223 |
Tick-borne encephalitis, inactivated, PF, 0.25mL |
Tick-borne encephalitis vaccine, inactivated, preservative free, 0.25mL dose |
Active |
False |
2022-03-03 |
224 |
Tick-borne encephalitis, inactivated, PF, 0.5mL |
Tick-borne encephalitis vaccine, inactivated, preservative free, 0.5mL dose |
Active |
False |
2022-03-04 |
225 |
COVID-19, D614, recomb, preS dTM, AS03 adjuvant add, PF, 5mcg/0.5mL |
SARS-COV-2 (COVID-19) vaccine, D614, prefusion spike recombinant protein subunit (CoV2 preS dTM), AS03 adjuvant added, preservative free, 5mcg/0.5mL dose |
Never Active |
False |
2023-03-09 |
226 |
COVID-19, D614, recomb, preS dTM, AS03 adjuvant add, PF, 10mcg/0.5mL |
SARS-COV-2 (COVID-19) vaccine, D614, prefusion spike recombinant protein subunit (CoV2 preS dTM), AS03 adjuvant added, preservative free, 10mcg/0.5mL dose |
Never Active |
False |
2023-03-09 |
512 |
SARS-COV-2 COVID-19 VLP Non-US Vaccine (Medicago, Covifenz) |
SARS-COV-2 COVID-19 Virus Like Particle (VLP) Non-US Vaccine Product (Medicago, Covifenz) |
Non-US |
False |
2022-04-12 |
513 |
SARS-COV-2 COVID-19 PS Non-US Vaccine (Anhui Zhifei Longcom, Zifivax) |
SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Anhui Zhifei Longcom, Zifivax) |
Non-US |
False |
2022-04-12 |
514 |
SARS-COV-2 COVID-19 DNA Non-US Vaccine (Zydus Cadila, ZyCoV-D) |
SARS-COV-2 COVID-19 DNA Non-US Vaccine Product (Zydus Cadila, ZyCoV-D) |
Non-US |
False |
2022-04-12 |
515 |
SARS-COV-2 COVID-19 PS Non-US Vaccine (Medigen, MVC-COV1901) |
SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Medigen, MVC-COV1901) |
Non-US |
False |
2022-04-12 |
516 |
COV-2 COVID-19 Inactivated Non-US Vaccine Product (Minhai Biotechnology Co, KCONVAC) |
SARS-COV-2 COVID-19 Inactivated Non-US Vaccine Product (Minhai Biotechnology Co, KCONVAC) |
Non-US |
False |
2022-04-12 |
517 |
SARS-COV-2 COVID-19 PS Non-US Vaccine (Biological E Limited, Corbevax) |
SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Biological E Limited, Corbevax) |
Non-US |
False |
2022-04-12 |
227 |
COVID-19, mRNA, LNP-S, PF, pediatric 50 mcg/0.5 mL dose |
SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, pediatric 50 mcg/0.5 mL dose |
Inactive |
False |
2023-10-26 |
228 |
COVID-19, mRNA, LNP-S, PF, pediatric 25 mcg/0.25 mL dose |
SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, pediatric 25 mcg/0.25 mL dose |
Inactive |
False |
2023-10-27 |
229 |
COVID-19, mRNA, LNP-S, bivalent, PF, 50 mcg/0.5 mL or 25mcg/0.25 mL dose |
SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 50 mcg/0.5 mL or 25 mcg/0.25 mL dose |
Inactive |
False |
2023-10-26 |
301 |
COVID-19, mRNA, LNP-S, bivalent, PF, 10 mcg/0.2 mL dose |
SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 10 mcg/0.2 mL dose, tris-sucrose formulation |
Inactive |
False |
2023-10-26 |
300 |
COVID-19, mRNA, LNP-S, bivalent, PF, 30 mcg/0.3 mL dose |
SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 30 mcg/0.3 mL dose, tris-sucrose formulation |
Inactive |
False |
2023-10-26 |
230 |
COVID-19, mRNA, LNP-S, bivalent, PF, 10 mcg/0.2 mL |
SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 10 mcg/0.2 mL dose |
Inactive |
False |
2023-10-26 |
518 |
COVID-19 Inactivated, Non-US Vaccine (VLA2001, Valneva) |
SARS-COV-2 COVID-19 Inactivated, Non-US Vaccine (VLA2001, Valneva) |
Non-US |
False |
2022-11-17 |
519 |
COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine (Spikevax Bivalent), Moderna |
SARS-COV-2 COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine (Spikevax Bivalent), Moderna |
Non-US |
False |
2022-11-17 |
520 |
COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine Product, Pfizer-BioNTech |
SARS-COV-2 COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine Product (Comirnaty Bivalent), Pfizer-BioNTech |
Non-US |
False |
2022-12-19 |
521 |
COVID-19 SP, protein-based, adjuvanted (VidPrevtyn Beta), Sanofi-GSK |
SARS-COV-2 (COVID-19) vaccine SP, protein-based, adjuvanted, B.1.351 strain (VidPrevtyn Beta), Sanofi-GSK |
Non-US |
False |
2024-01-03 |
231 |
influenza, Southern Hemisphere, high-dose, quadrivalent |
influenza, seasonal, Southern Hemisphere, high-dose, quadrivalent, 0.7mL dose, preservative free |
Active |
False |
2023-03-14 |
303 |
RSV, recombinant, protein subunit RSVpreF, adjuvant reconstituted, 0.5 mL, PF |
Respiratory syncytial virus (RSV), vaccine, recombinant, protein subunit RSV prefusion F, adjuvant reconstituted, 0.5 mL, preservative free |
Active |
False |
2023-06-06 |
304 |
Respiratory syncytial virus (RSV), unspecified |
Respiratory syncytial virus (RSV), unspecified |
Inactive |
False |
2024-01-03 |
305 |
RSV, bivalent, protein subunit RSVpreF, diluent reconstituted, 0.5 mL, PF |
Respiratory syncytial virus (RSV), vaccine, bivalent, protein subunit RSV prefusion F, diluent reconstituted, 0.5 mL, preservative free |
Active |
False |
2023-07-13 |
306 |
RSV, mAb, nirsevimab-alip, 0.5 mL, neonate to 24 months |
Respiratory syncytial virus (RSV) monoclonal antibody, IgG1κ, (nirsevimab-alip), 0.5 mL, neonates and children to 24 months |
Active |
False |
2023-07-25 |
307 |
RSV, mAb, nirsevimab-alip, 1 mL, neonate to 24 months |
Respiratory syncytial virus (RSV) monoclonal antibody, IgG1κ, (nirsevimab-alip), 1 mL, neonates and children to 24 months |
Active |
False |
2023-08-09 |
313 |
COVID-19, subunit, rS-nanoparticle, adjuvanted, PF, 5 mcg/0.5 mL |
SARS-COV-2 (COVID-19) vaccine, subunit, recombinant spike protein-nanoparticle+Matrix-M1 Adjuvant, preservative free, 5 mcg/0.5 mL dose |
Active |
False |
2023-09-01 |
308 |
COVID-19, mRNA, LNP-S, PF, tris-sucrose, 3 mcg/0.3 mL |
SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, tris-sucrose, 3 mcg/0.3 mL dose |
Active |
False |
2023-09-13 |
309 |
COVID-19, mRNA, LNP-S, PF, tris-sucrose, 30 mcg/0.3 mL |
SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, tris-sucrose, 30 mcg/0.3 mL dose |
Active |
False |
2023-09-13 |
310 |
COVID-19, mRNA, LNP-S, PF, tris-sucrose, 10 mcg/0.3 mL |
SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, tris-sucrose, 10 mcg/0.3 mL dose |
Active |
False |
2023-09-13 |
312 |
COVID-19, mRNA, LNP-S, PF, 50 mcg/0.5 mL |
SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 50 mcg/0.5 mL dose |
Active |
False |
2023-09-13 |
311 |
COVID-19, mRNA, LNP-S, PF, 25 mcg/0.25 mL |
SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 25 mcg/0.25 mL dose |
Active |
False |
2023-09-13 |
315 |
Respiratory syncytial virus (RSV) MAB, unspecified |
Respiratory syncytial virus (RSV) monoclonal antibody (MAB), unspecified |
Inactive |
False |
2023-09-19 |
314 |
Respiratory syncytial virus (RSV) vaccine, unspecified |
Respiratory syncytial virus (RSV) vaccine, unspecified |
Inactive |
False |
2023-09-19 |
316 |
Meningococcal polysaccharide (MenACWY-TT conjugate), (MenB), PF |
Meningococcal polysaccharide (groups A, C, Y, W) tetanus toxoid conjugate, meningococcal B recombinant vaccine, 0.5mL, preservative free |
Active |
False |
2024-01-25 |
317 |
Chikungunya live attenuated vaccine, 0.5 mL, PF |
Chikungunya, live attenuated vaccine, 0.5 mL, preservative free |
Active |
False |
2023-12-20 |
318 |
Anthrax, post-exposure prophylaxis |
Anthrax vaccine, adsorbed, adjuvanted, post-exposure prophylaxis |
Active |
False |
2024-01-25 |
319 |
Anthrax vaccine, unspecified |
Anthrax vaccine, unspecified |
Inactive |
False |
2024-03-15 |
302 |
COVID-19, mRNA, LNP-S, bivalent, PF, 3 mcg/0.2 mL dose |
SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 3 mcg/0.2 mL dose, tris-sucrose formulation |
Inactive |
False |
2023-10-26 |